Black Coshosh: Another herbal cure proves worthless

OK now I KNOW I must be on ignore. I've posted a snippet and a link twice now, to

Archives Of Internal Medicine Article Finds One Black Cohosh Effective For Treating Menopausal Symptoms


A July 24 review article published in the Archives of Internal Medicine (2006;166:1453-1465) concluded that alternative and complementary therapies are generally ineffective for treating menopause-related symptoms. Among the biologically based studies, only one on Remifemin(R) out of the four black cohosh studies reviewed, was shown to be effective.
http://www.medicalnewstoday.com/articles/48394.php

And somehow it just doesn't seem to show up for some people. Pity. One can look dumb from ignoring stuff.
 
Do you have me on ignore or something?
Sorry, who are you again.....?
;)
I've posted multiple links to both studies as well as Medical papers showing results, and the reasons for them.

Ignoring stuff can make you look dumb you know. :wackywink:
God forbid!
My stupid - I should have said that Robinson has also cited trials showing some efficacy.
 
Last edited:

Good. An example of a double-blind, randomized, placebo-controlled trial.


The rest of these are not. And ultimately the problem is that without those constraints, there are multiple explanations for the differences found in the studies, with no good way to distinguish between them. It is also a problem that you didn't include the negative studies.

ETA: Oops. I should have given you credit for mentioning the negative studies in an earlier link. Ignore that last sentence.

Linda
 
Last edited:
Here is the study mentioned in the OP, which has a broken link now.
http://jco.ascopubs.org/cgi/reprint/24/18/2836?ck=nck
Purpose
Hot flashes can cause significant morbidity in postmenopausal women undergoing or finished with
breast cancer treatment. Black cohosh has been used to treat hot flashes, but definitive clinical
data about efficacy have been equivocal.
Methods
A double-blind, randomized, cross-over clinical trial with two 4-week periods, was used to study
the efficacy of black cohosh (1 capsule, Cimicifuga racemosa 20 mg BID) for the treatment of hot
flashes in women. Participants kept a daily hot flash diary during a baseline week and then during
two 4-week crossover treatment periods. Hot flash scores were measured by assigning points (1
to 4 for mild to very severe) to each hot flash based on severity and then adding the points for a
given time period.
Results
Between October 31, 2003, to March 4, 2004, 132 patients were randomly assigned. Toxicity was
minimal and not different by treatment group. Patients receiving black cohosh reported a mean
decrease in hot flash score of 20% (comparing the fourth treatment week to the baseline week)
compared with a 27% decrease for patients on placebo (P  .53). Mean hot flash frequency was
reduced 17% on black cohosh and 26% on placebo (P  .36). Patient treatment preferences were
measured after completion of both treatment periods by ascertaining which treatment period, if
any, the patient preferred. Thirty-four percent of patients preferred the black cohosh treatment,
38% preferred the placebo, and 28% did not prefer either treatment.
Conclusion
This trial failed to provide any evidence that black cohosh reduced hot flashes more than
the placebo.
 
Vaidya and Robinson, this appears to be the most up-to-date scientific evidence on black cohosh (and herbal medicine):

Black cohosh: Risk-benefit assessment

Systematic reviews report promising but not compelling evidence of black cohosh for treating symptoms associated with menopause. Its adverse effects profile for short-term application is encouraging and it seems worth considering for symptoms associated with menopause. However, more clinical data are required. Conflicting evidence exists on its alleged oestrogen-like activity and its effects in oestrogen-dependent tumours. Thus it seems wise to view the latter condition as a contraindication for black cohosh extract.


The Desktop Guide to Complementary and Alternative Medicine, 2nd edition (2006), p.374
http://www.elsevierhealth.co.uk/catalogue/title.cfm?ISBN=0723433836
A systematic review of randomised clinical trials of individualised herbal medicine in any indication

Conclusion: Individualised herbal medicine, as practised in European medical herbalism, Chinese herbal medicine and Ayurvedic herbal medicine, has a very sparse evidence base and there is no convincing evidence that it is effective in any indication. Because of the high potential for adverse events and negative herb–herb and herb–drug interactions, this lack of evidence for effectiveness means that its use cannot be recommended.

R Guo , P H Canter , E Ernst, Postgraduate Medical Journal 2007;83:633-637
http://pmj.bmj.com/cgi/content/full/83/984/633


Do you dispute these findings?
 
And ultimately the problem is that without those constraints, there are multiple explanations for the differences found in the studies, with no good way to distinguish between them. It is also a problem that you didn't include the negative studies.

No, those are not problems. And here is why.

A July 24 review article published in the Archives of Internal Medicine (2006;166:1453-1465) concluded that alternative and complementary therapies are generally ineffective for treating menopause-related symptoms. Among the biologically based studies, only one on Remifemin(R) out of the four black cohosh studies reviewed, was shown to be effective.

"A single large trial showed a benefit for vasomotor symptoms with the black cohosh Remifemin(R) (Enzymatic Therapy Inc., Green Bay Wisconsin) and is consistent with older German studies," the reviewers wrote, indicating that the remaining three studies showed no benefits from black cohosh. Results from two "were confounded by concurrent use of tamoxifen, known to exacerbate hot flashes," while another used a "more unusual (research) preparation, BN01055."

See? The people that write in professional journals know more than I do, and have greater access to data, so I bow to their judgment.

A single large trial showed a benefit for vasomotor symptoms with the black cohosh Remifemin(R) (Enzymatic Therapy Inc., Green Bay Wisconsin) and is consistent with older German studies

See? "consistent with older German studies" means the large new trial found the same results as the other studies, that it worked, in regards to their criteria. That is how science works.

Claiming "Black Coshosh: Another herbal cure proves worthless", based on a flawed study, is not science (and bad spelling too). A look at the actual data is enough to show that they repeated the mistakes of the other studies.

Using a quality extract (Remifemin), and using the correct dosage, you get the same results, that it works.
 
One accepted standardised method of rating menopausal symptoms seems to be ...(wait for it)... the Menopause Rating Scale. There is also the "Kupperman Index". Trials of interventions for menopause generally refer to one or other scale, some only to individual symptoms (eg flushes).
 
The three studies quoted here
http://www.internationalskeptics.com/forums/showthread.php?postid=3307525#post3307525 show an obvious effect. Claiming "it could be wishful thinking" is not scientific, nor along the lines of evidence based medicine. This sort of blindness about scientific studies, where a conclusion is reached before looking at evidence, is the opposite of the scientific method.

This was the trouble, except the study which used St John's Wood, they were not blinded.

Studies, especially ones that test the difference between two herbal formulas, do not exist in a vacuum. When research is done on differences, it is to examine what adding something does, not looking for an effect. Black Cohosh is already known to have an effect, the one study was looking at what adding another herb did.

Even a casual look at the wealth of data on Black Cohosh shows scientific evidence for having biological activity, that can both be measured, as well as understood.

Apart from the anecdotes and the poor studies above, where is this scientific data, that is what we have been trying to find.


Thanks for the link to the abstract.

http://pubs.acs.org/cgi-bin/abstract.cgi/jafcau/2006/54/i26/abs/jf062808u.html


The double standard used by skeptics when it comes to science they don't like, is often amusing. Rather than admit a point, they want to move the goalpost, or focus on unrelated issues. A study that used the exact same method to determine the toxicity of a known drug, Taxol, wouldn't raise an eyebrow.


http://www.springerlink.com/content/u87p68017244m315/

See? Human ovarian cells in hamsters are used all the time to do testing. But when a result goes against your belief system, somehow it doesn't mean anything. Madness.

Talk about blindness. The study you quoted doesn't even use the same cells as the study originally quoted by Vaidya. It shows the difference in cytotoxicity in vitro between normal Chinese Hamster Ovarian (CHO) cells and human ovarian carcinoma cells. It confirmed results from other studies that Taxol is more cytotoxic in carcinoma cells than in CHO cells. It is also telling that the authors did not make claims outside the small area of their own experiment.



Such claims, while they sound good, are just something you made up. You don't actually know anything about the millions of herbalist worldwide, or how they think, work and research science. Your sweeping statement is simply woo. You have no research, no evidence, nothing to base your claim on. Yet such behavior is exactly what you purport to be against.

I make my observations based on 1) The herbalists I see trying to defend products which have no demonstrable effect and could be dangerous and 2) the vast amounts of poor research.

Even a cursory look at the vast amounts of research on medicinal herbs shows a keen interest in both establishing potency, standards, and finding ways to isolate and extract the active ingrediants from plants.
I'll take your word for keen interest. The problem is that you cannot standardise a complex mixture of chemicals by a chemical test on one of them. CH contains many chemicals and has claimed effects of estrogenic and opioid activity, as well as liver toxicity. Are all these from 26-deoxyactein? Because if they are not nobobdy knows what doses are being used.

In the past, herbalist faced huge problems with obtaining and storing plants and their extracts. As well as knowing the potency of the product. This same problem exist today. Anyone who has bought a bag of herb knows the importance of determining quality, hopefully before the transaction. And you who have indeed bought and consumed a medicinal herb, might laugh along with us, when some skeptic tries to tell you that the effect might just be wishful thinking.... :wackywink:

Humans can become quite adept at evaluating the potency of an herbal product. Be it Coffee, or some other potent brew nature serves up, on a regular basis.

Nobody doubts that there are chemicals in plants that are active in humans. What is doubtful is that humans are capable of deciding what is useful or not based on anecdotal evidence. The malaria treatment Artemisin is a good example and has been discussed on the forums before. The Chinese tested all the TCM (300 of them) for their claimed anti-malarial activity. They found one that worked. What about the other 299 or so? How adept were the TCM practitioners in dosing people with all these preparations when they didn't work.
 
Last edited:
Re this paper from the OP:
http://jco.ascopubs.org/cgi/reprint/24/18/2836?ck=nck

Claiming "Black Coshosh: Another herbal cure proves worthless", based on a flawed study, is not science (and bad spelling too). A look at the actual data is enough to show that they repeated the mistakes of the other studies.

Using a quality extract (Remifemin), and using the correct dosage, you get the same results, that it works.
What exactly are the flaws/mistakes in this study?
The authors used a preparation identical to remifemin, and at a standard dosing (40mg/d).

A reminder....
See? The people that write in professional journals know more than I do, and have greater access to data, so I bow to their judgment.

The literature is rather conflicting however. Which people's judgement do you bow to? How do you decide?

You/others have already referred to this positive German trial.
Determining relative merits of one study over another will take some time (which I haven't got at the moment), but I'd appreciate your own take on these studies' problems/flaws/mistakes.
 
Last edited:
No, those are not problems. And here is why.

See? The people that write in professional journals know more than I do, and have greater access to data, so I bow to their judgment.

A single large trial showed a benefit for vasomotor symptoms with the black cohosh Remifemin(R) (Enzymatic Therapy Inc., Green Bay Wisconsin) and is consistent with older German studies

See? "consistent with older German studies" means the large new trial found the same results as the other studies, that it worked, in regards to their criteria. That is how science works.

Claiming "Black Coshosh: Another herbal cure proves worthless", based on a flawed study, is not science (and bad spelling too). A look at the actual data is enough to show that they repeated the mistakes of the other studies.

Using a quality extract (Remifemin), and using the correct dosage, you get the same results, that it works.

That simply illustrates my point. The authors based their conclusions about whether or not Black Cohosh is effective on the results of a DBPCRCT - it was a necessary piece of information.

Linda
 
What exactly are the flaws/mistakes in this study?
The authors used a preparation identical to remifemin, and at a standard dosing (40mg/d).

Where do you get that from? The study did NOT use Remifemin, hence the obvious flaw.

The literature is rather conflicting however. Which people's judgement do you bow to? How do you decide?

In this case I tend to trust the Medical Journals. Here is one reason why.

Menopause. 2003 Jan-Feb;10(1):58-64.
A systematic review of the safety of black cohosh.
http://www.ncbi.nlm.nih.gov/pubmed/...ez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
OBJECTIVE: To systematically review the available data relating to the safety of medicinal extracts of black cohosh (Actaea racemosa).
DESIGN: Systematic literature searches were conducted in seven electronic databases, and the reference lists of all papers located were checked for further relevant publications. Information was also sought from the spontaneous reporting programs of the World Health Organization and national drug safety bodies. Sixteen manufacturers of black cohosh preparations were contacted and asked for data held on file. Finally, our own departmental files were searched. No language restrictions were imposed. Combination products and homeopathic preparations were excluded.

See? They have vastly superior data to draw on, and expertise in the field.

And again:

Am J Med. 2005 Dec 19;118 Suppl 12B:98-108.
Menopause: a review of botanical dietary supplements.
The majority of studies indicate that extract of black cohosh (Actaea racemosa L.) improves menopause-related symptoms; however, methodologic shortcomings in the trials were identified. To date, 4 case reports of possible hepatotoxicity have been published, although previous safety reviews suggest that black cohosh is well tolerated and that adverse events are rare when it is used appropriately.
http://www.ncbi.nlm.nih.gov/pubmed/...med.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

And again-

Adv Ther. 1998 Jan-Feb;15(1):45-53.
Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders.
Liske E.

Schaper & Brümmer GmbH & Co. KG, International Sales Division, Salzgitter-Ringelheim, Germany.
The reproducible quality of phytopharmaceuticals--herbal medicines--is an essential prerequisite for good efficacy and tolerability in the treatment of functional disorders. In clinical trials and scientific investigations, standardized assessments (i.e., validated, internationally recognized and accepted scales) provide the basis for establishing clinical efficacy and tolerability. Extracts (ethanolic and isopropanolic aqueous, Remifemin) of the rootstock of the herb Cimicifuga racemosa (black cohosh) are active ingredients developed for the treatment of gynecologic disorders, particularly climacteric symptoms. Drug-monitoring and clinical studies documenting experience with C. racemosa rootstock extracts comprise the database of this herbal treatment for menopausal symptoms (e.g., hot flashes, profuse sweating, sleep disturbances, depressive moods). These studies show good therapeutic efficacy and tolerability profiles for C. racemosa. In addition, clinical and experimental investigations indicate that the rootstock of C. racemosa does not show hormone-like activity, as was originally postulated.

There are many more studies, but I tend to trust experts in this case, because I have little interest in actually taking the stuff. :D
 
Originally Posted by Deetee
What exactly are the flaws/mistakes in this study?
The authors used a preparation identical to remifemin, and at a standard dosing (40mg/d).
Where do you get that from? The study did NOT use Remifemin, hence the obvious flaw.


No, but it seemed to use as near enough an identical preparation, based on HPLC and proton nuclear magnetic resonance:
The dose chosen was based on the recommended dose of the most commonly marketed black cohosh product in the United States (Remifemin; GlaxoSmithKline, Research Triangle Park, NC). Being unable to obtain remifemin and placebos from GlaxoSmithKline, another source of black cohosh was obtained. The product and matching placebos for this study were supplied by Hi-Health Corporation, Scottsdale, Arizona. In order to verify that this product was similar to the most commonly studied commercially available black cohosh product, Remifemin, proton nuclear magnetic resonance and high performance liquid chromatography (HPLC) analyses were performed. To perform the proton nuclear magnetic resonance (HNMR) analysis, 10 mg of powdered remifemin and the study black cohosh tablets were dissolved by vortexing the samples in 0.5 mL of dimethyl sulfoxide (DMSO.d6; six deuterium atoms). The proton nuclear magnetic resonance spectra of the resulting solutions were measured and were found to be almost identical for the two extracts. Then 10 mg of each compound were separately extracted from 1 mL methanol and 40% aqueous isopropanol alcohol. A total of 20 microliters of each was injected into a 126-Beckman HPLC instrument with 166 ultraviolet detector (flow rate 1.5 mL/min;
lgr.gif
maximum, 254 nm; linear gradient 10% B to 100% B in 30 minutes where B = 0.1% trifluoroacetic acid and A = 80% acetonitrile in 0.1% trifluoroacetic acid). Again, the general HPLC profiles were found to be very nearly identical. During the HPLC, three prominent peaks were manually collected and analyzed by infusion of methanolic and aqueous isopropanolic extracts on a Sciex-265 Triple Quadrupole mass spectrometer (Applied Biosystems, Forest City, CA). The fingerprint spectra were measured under two different orifice and ring voltages (400 and 200 for orifice and 74 and 35 for the ring). The mass spectrometry spectra showed very similar peak pattern under both conditions of measurement. Based on this analysis, both compounds had very similar HNMR and HPLC profiles.
So yours seems a very dubious point to me.

Now what were the other major "flaws" in this study again?


There are many more studies, but I tend to trust experts in this case, because I have little interest in actually taking the stuff. :D
My point was that when the experts arrive at different conclusions, how do you decide which experts to believe?

It appears as though you have decided in advance what you would like to believe, and dismiss the view of the experts who disagree by finding non-existent/imagined flaws with their expert conclusions. That is not being objective. I really expected more from you, Robinson.
 
Last edited:
My point was that when the experts arrive at different conclusions, how do you decide which experts to believe?

That is always a tough one. In this case, Black Cohosh and female troubles, it has little bearing on my life, so I chose the easy way out, and went with the Archives of Internal Medicine. It is professional medical journal published by the American Medical Association, a group not known for any tolerance of alternative medicine. More than enough to meet my standards in this case.

This is backed up by the extensive scientific evidence from Germany.
 
OK I did, and found this:

Remifemin(R)/Black Cohosh Reduces Menopausal Symptoms and Protects Against Breast Cancer
4/24/2007

The results demonstrated that while 15 of the 17 supplements revealed no significant relationship, women who reported using black cohosh/Remifemin(R) had a 60% lower risk of developing breast cancer than the women who did not use these supplements. The study also demonstrated that no significant interaction between tamoxifen/raloxifene use and use of any herbal preparation or black cohosh use was observed.

"These findings complement a safety study published in Menopause: The Journal of The North American Menopause Society, 14:1 (2007), which showed that Remifemin(R) does not augment breast cancer risk factors as HRT does," explained Dr. Liske. "Hirschberg's research showed that Remifemin(R) does not promote endometrial thickening, increased breast density and breast cell proliferation, and is safe-particularly for women who should not take estrogen. In addition to HRT, many dietary supplements have failed to pass the safety test for breast cancer risk factors."

"Not all black cohosh is the same," concluded Dr. Liske. "Remifemin(R) is produced using a proprietary standardized extract (uniform dosage) of pure black cohosh root called RemiSure(TM) that yields a more complete spectrum of active compounds than other extraction methods. With 90 scientific papers and more than 15 published studies, Remifemin(R) demonstrates consistent positive results, unlike other black cohosh preparations. Remifemin(R) is safe and effective, and now we see that it also shows promise for preventing breast cancer."
http://www.wisbusiness.com/index.iml?Article=94197
 
With 90 scientific papers and more than 15 published studies, Remifemin(R) demonstrates consistent positive results, unlike other black cohosh preparations. Remifemin(R) is safe and effective, and now we see that it also shows promise for preventing breast cancer."

What experts do you trust in this matter?
 
With 90 scientific papers and more than 15 published studies, Remifemin(R) demonstrates consistent positive results, unlike other black cohosh preparations. Remifemin(R) is safe and effective, and now we see that it also shows promise for preventing breast cancer."

What experts do you trust in this matter?


So what are you now - a Glaxo Smith Kline pharma shill??
;)
 

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom